Low-Risk TAVR Loses Ground at 2 Years in PARTNER 3 Low-Risk TAVR Loses Ground at 2 Years in PARTNER 3

Transcatheter aortic valve replacement (TAVR) continued to show superiority over surgical replacement at 2 years ' follow-up, but between-group differences narrowed considerably.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news